Crossmark

The clinical effectiveness of sivelestat in treating sepsis patients with both acute respiratory distress syndrome and septic cardiomyopathy

Published Online: 2024-06-27

Authors

Lv, Hui

Huang, Langjing

Yang, Xiuhong

Zhang, Changdong

Yu, Hao

Shang, Xiaoke
Funding

Funding for this research was provided by:

National Natural Science Foundation of China ((81700339), (81700339), (81700339), (81700339), (81700339), (81700339))

National Key Research and Development Program of China ((No.2016YFA0101100,2016YFA0100900), (No.2016YFA0101100,2016YFA0100900), (No.2016YFA0101100,2016YFA0100900), (No.2016YFA0101100,2016YFA0100900), (No.2016YFA0101100,2016YFA0100900), (No.2016YFA0101100,2016YFA0100900))
License Information

Text and Data Mining valid from 2024-06-27

Version of Record valid from 2024-06-27
More Information

Article History

Received: 9 January 2024

Accepted: 14 June 2024

First Online: 27 June 2024

Declarations

:

: The study approved by the ethics committee of Wuhan Union Hospital (No. 2018-0598-08). We certify that the study was performed in accordance with the 1964 declaration of HELSINKI and later amendments. All methods were carried out in accordance with relevant guidelines and regulations. Informed consents were obtained from all subjects and/or their legal guardians.

: Not applicable.

: The authors declare no competing interests.

Document is current